Benjamin F. Edwards & Company’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $4K | Buy |
90
+56
| +165% | +$2.49K | ﹤0.01% | 1955 |
|
|
2024
Q1 | $2K | Buy |
+34
| New | +$2K | ﹤0.01% | 2038 |
|
|
2022
Q2 | – | Sell |
-46
| Closed | -$3K | – | 1881 |
|
|
2022
Q1 | $3K | Sell |
46
-688
| -94% | -$44.9K | ﹤0.01% | 1621 |
|
|
2021
Q4 | $62K | Hold |
734
| – | – | ﹤0.01% | 995 |
|
|
2021
Q3 | $66K | Buy |
+734
| New | +$66K | ﹤0.01% | 960 |
|